BIO 3.0: How the Biotech Trade Association is Reinventing Itself for a Changing Political Environment

2 blank lines

<div id="cincopa_049ad3" style="border:solid;border-width:1px"></div><script type="text/javascript">
var cpo = []; cpo["_object"] ="cincopa_049ad3"; cpo["_fid"] = "A0FAK8O3PJSi";
var _cpmp = _cpmp || []; _cpmp.push(cpo);
(function() { var cp = document.createElement("script"); cp.type = "text/javascript";
cp.async = true; cp.src = "https://rtcdn.cincopa.com/libasync.js";
var c = document.getElementsByTagName("script")[0];
c.parentNode.insertBefore(cp, c); })(); </script>

On-Demand Webinar - BIO - Video

<br><div style="padding-right:60px;">
### ON-DEMAND RECORDING
**RECORDED: April 1, 2021** <br><br>

Michelle McMurry-Heath assumed the leadership of the Biotechnology Innovation Organization (BIO) as President and CEO in May of 2020, when America was at an inflection point. The Economy had shut down. No one knew that over the next 10 months, almost 3 million people around the world would die from COVID, or that stunningly effective vaccines pioneered by biotechs would be developed in record time.
<br><br>

How has McMurry-Heath handled her 10 months as BIO CEO and President during one of America’s most tumultuous periods in history and how will the organization adapt to meet a quickly changing world?

</div>
<br><br>

On-Demand Webinar - BIO - Description

<br>
### HOSTED BY
<br><br>
<p>
<img src="https://media.graphassets.com/Uw0f60cZQvuhNRZYAhzJ" alt="BioCentury Logo" width="250" style="horizontal-align:center"><br><br><br>
<img src="https://media.graphassets.com/l5auGqA7S6KknJ7wEpEG" alt="Owkin Logo" width="250" style="horizontal-align:center"></p>


On-Demand Webinar - BIO - Hosted By BC & BIO

1 blank line

Washington Editor & Head of Policy & Regulation

Steve Usdin

Paul Hastings

Former Chair, Biotechnology Innovation Organization (BIO) and

Jeremy Levin (林伟峻) D.Phil, MB BChir

President & CEO

Michelle McMurry Heath, M.D., Ph.D.

Jeremy Levin, D.Phil, MB BChir

3 blank lines

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

East-West Healthcare Reception

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

BioCentury Grand Rounds Inquiry

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Michelle McMurry-Heath assumed leadership of the Biotechnology Innovation Organization in May, 2020, when the economy had shut down. No one knew that over the next 10 months, almost 3 million people around the world would die from COVID, or that stunningly effective vaccines pioneered by biotechs would be developed in record time.